Nanohale AG (FYB) | WebDisclosure

Basculer en Français

8306	Companies
115328	Keywords
55598	Articles
62613	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 05/15/2024 at 07:35, 6 months 7 days ago

MS Pharma s'associe à Formycon pour la commercialisation du FYB203 dans la région MENA

MS Pharma Région MENA Formycon Biosimilaire FYB203
PRESS RELEASE

published on 05/15/2024 at 07:30, 6 months 7 days ago

MS Pharma becomes Partner for the Commercialization of FYB203, Formycon’s Biosimilar Candidate to Eylea® (Aflibercept), in the MENA Region
Formycon AG partners with MS Pharma for commercializing FYB203, a biosimilar candidate to Eylea in the MENA region, strengthening biosimilar portfolio and local production

Formycon AG MS Pharma Biosimilar FYB203 Eylea
BRIEF

published on 05/08/2024 at 07:35, 6 months 14 days ago

Formycon Reports Steady Performance in Q1 2024 Despite Challenges

Formycon AG Q1 2024 Financial Results Biosimilars Development Gedeon Richter Partnership Biopharmaceutical Market
BRIEF

published on 05/08/2024 at 07:35, 6 months 14 days ago

Formycon annonce des performances stables au premier trimestre 2024 malgré les défis

Formycon AG Résultats Financiers Du Premier Trimestre 2024 Développement De Biosimilaires Partenariat Gédéon Richter Marché Biopharmaceutique
PRESS RELEASE

published on 05/08/2024 at 07:30, 6 months 14 days ago

Formycon reports on successful operating business and financial figures for the first quarter of 2024
Formycon reports successful Q1 2024 operating business and financial figures, including acquisitions and strategic investments. Revenue at €17.7 million. Invitation to conference call

Acquisitions Financial Figures Strategic Investments Q1 2024 Formycon
BRIEF

published on 05/07/2024 at 11:05, 6 months 15 days ago

Formycon Announces Key Details for Annual General Meeting 2024 and Changes in Supervisory Board

Annual General Meeting Corporate Governance Supervisory Board Formycon AG Biosimilars
BRIEF

published on 05/07/2024 at 11:05, 6 months 15 days ago

Formycon annonce les détails clés de l'Assemblée générale annuelle 2024 et des changements au sein du conseil de surveillance

Gouvernance D'Entreprise Formycon AG Conseil De Surveillance Assemblée Générale Annuelle Biosimilaires
PRESS RELEASE

published on 05/07/2024 at 11:00, 6 months 15 days ago

Formycon invites to the Annual General Meeting on June 12, 2024 in Munich
Formycon AG invites shareholders to Annual General Meeting in Munich on June 12, 2024, to elect new Supervisory Board members and expand the board to enhance international focus and expertise

Annual General Meeting Financial Expertise Supervisory Board Formycon AG International Focus
BRIEF

published on 05/02/2024 at 07:35, 6 months 20 days ago

Formycon AG Announces First Quarter 2024 Conference Call

Conference Call Investor Conferences Formycon AG Financial Outlook Q1 2024 Results
BRIEF

published on 05/02/2024 at 07:35, 6 months 20 days ago

Formycon AG annonce une conférence téléphonique pour le premier trimestre 2024

Formycon AG Conférence Téléphonique Perspectives Financières Conférences Investisseurs Résultats Du Premier Trimestre 2024

Accesswire

Published on 11/22/2024 at 16:00, 1 hour 26 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 1 hour 31 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 2 hours 11 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 2 hours 41 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 2 hours 56 minutes ago

Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 16:55, 30 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 hour 25 minutes ago

Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 1 hour 25 minutes ago

AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 1 hour 59 minutes ago

EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 2 hours 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company

Les Echos

Published on 11/22/2024 at 16:15, 1 hour 10 minutes ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 2 hours 50 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 2 hours 50 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 10 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 10 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE